The email always seems to arrive on a Friday. “We’ve reviewed your account and determined that your business violates our terms of service. Your account has been deactivated, and your remaining balance will be held for 180 days.”
Ask around the peptide industry and you’ll find this story everywhere: a company builds steady volume on Stripe or PayPal, an underwriting review finally looks closely at the product catalog, and overnight the business loses both its ability to take payments and six months of access to its own money.
That risk is baked into what peptide companies pay to process cards — and it’s why quotes in this space look nothing like the flat 2.9% the rest of e-commerce enjoys. This guide breaks down every line on a peptide payment processing quote, shows you which fees are legitimate and which are padding, gives you a real cost comparison, and ends with the questions that separate a fair processor from an expensive mistake.
Why Peptide Companies Pay More in the First Place
Card networks and processors price risk, and peptides carry three kinds of it.
First, regulatory ambiguity. Research-use-only peptides sit in a space the FDA watches closely — the agency has issued warning letters to sellers over marketing claims — and card networks treat regulatory gray zones as financial exposure. That’s why Stripe, PayPal, and Square all place research chemicals and pseudo-pharmaceutical products on their restricted or prohibited business lists. It’s not personal; it’s their own risk math.
Second, registration overhead. Merchants in card-network high-risk categories often must be registered by their acquirer with Visa and Mastercard, at fees commonly around $500 per network, per year — a cost that flows into your pricing.
Third, chargebacks. Peptides are consumable, shipped, and card-not-present, a combination that produces elevated dispute rates. Every processor pricing your account is pricing that in.
Understand those three drivers and the rest of the quote stops looking arbitrary.
Also Read : why-stripe-paypal-reject-peptide-merchants
The Fee Stack, Line by Line
Interchange and assessments form the non-negotiable base. Interchange goes to the cardholder’s bank and typically runs 1.5–2.4% for card-not-present transactions; network assessments add roughly another 0.13–0.14%. No processor controls these. Anyone claiming to discount them is moving the cost somewhere else on your statement.
The discount rate is the headline number — the processor’s total percentage per sale. Across the high-risk market, peptide merchants typically see 3.5–6%. Under about 3.5%, be skeptical of what’s hidden; above 6%, you’re likely subsidizing someone’s margin, not your risk profile.
Per-transaction fees usually land between $0.25 and $0.50 in high-risk processing, versus $0.10–$0.30 in standard e-commerce. On small average orders, this line matters more than the percentage.
Monthly costs — gateway, statement, and account fees — commonly total $20–$60. Watch for monthly minimums: a $250 minimum is irrelevant at $80,000 in volume and painful at $8,000.
The rolling reserve is the line that surprises new merchants most. Processors hold back 5–10% of your sales for 90–180 days as a cushion against future chargebacks, releasing funds on a rolling basis. At $50,000 in monthly volume with a 10% reserve held for 180 days, that’s $5,000 withheld each month and up to $30,000 of your cash sitting in escrow at steady state. A reserve isn’t a scam — it’s standard for the category — but the percentage and hold period are negotiable, and they should shrink as you build clean history.
Chargeback fees run $25–$100 per dispute, charged win or lose. Pair this line with real prevention tools, or it compounds fast.
Setup and exit costs round out the stack: application or setup fees (often $0–$500) and early termination fees buried in multi-year contracts. A processor confident in its service doesn’t need a three-year lock-in to keep you.
The Comparison: Standard vs. Typical High-Risk vs. Fair
| Fee line | Standard e-commerce* | Typical high-risk quote | What fair looks like |
| Discount rate | 2.6–2.9% | 4–6% | 3.5–4.5%, interchange-plus if possible |
| Per transaction | $0.10–$0.30 | $0.30–$0.50 | ≤ $0.35 |
| Monthly fees | $0–$10 | $30–$60 + minimums | $20–$40, minimum matched to your volume |
| Rolling reserve | None | 10% / 180 days | 5% / 90 days, with scheduled review |
| Chargeback fee | $15–$25 | $50–$100 | $25–$45, with alerts included |
| Settlement | 1–2 days | 3–7 days | 2–3 days |
| Contract | Month-to-month | 3 years + termination fee | 1 year or month-to-month |
*Standard pricing shown for context only — mainstream processors don’t knowingly accept peptide merchants, which is exactly the problem.
What Actually Moves Your Rate
Your quote isn’t fixed by the word “peptide.” Underwriters price the specific business in front of them, and four things consistently earn better terms.
A clean compliance posture comes first: accurate product descriptions, clear research-use terms, no medical or dosage claims anywhere on the site, and published refund policies. Underwriters read your website before they price you — a tidy one reads as lower risk because it is lower risk.
Then come chargeback controls (dispute alerts, clear billing descriptors, responsive support), processing history (three to six months of low disputes justifies a reserve reduction — put a review date in the contract), and volume, which improves your negotiating position on every line above.
One thing that never works: describing your business as something it isn’t to reach cheaper standard rates. Miscoded accounts get terminated, funds get held, and the business often lands on Mastercard’s MATCH list — a five-year flag that makes every future processor either decline you or price you as radioactive. This is the pattern Great West Pay sees behind the worst quotes in the industry: merchants paying a distressed-account premium for someone else’s shortcut two years earlier.
Also Read : tired-of-waiting-unpacking-why-your-payment-processing-might-be-slow
“But Stripe Is So Much Cheaper — Why Not Use It Until They Notice?”
Run the math on a real merchant doing $60,000 a month.
On a standard 2.9% + $0.30 setup, processing costs about $1,840 a month. On an honest high-risk account at 4.5% + $0.35, it’s roughly $2,820. The gap — call it $1,000 a month — feels like pure savings.
Now price the ending. A termination freezes your incoming balance, commonly for 180 days; on this merchant’s volume, that’s easily $25,000–$30,000 of working capital gone for half a year, during peak season or not. Add the scramble for emergency processing at distressed rates, the MATCH-list shadow over every future application, and revenue lost while checkout is down.
The 2.9% rate isn’t a price. It’s a loan — and the repayment terms are brutal. Stable processing at 4.5% isn’t the expensive option; it’s the insured one.
Your Pre-Signing Checklist
- Ask for interchange-plus pricing or, at minimum, a full fee schedule in writing — every line, not just the headline rate.
- Get the reserve terms specified: percentage, hold period, and a scheduled review after 3–6 months of clean processing.
- Confirm who the acquiring bank is and that it knowingly accepts research peptide merchants. “Don’t worry about it” is a red flag, not an answer.
- Check the contract exit: term length, termination fee, and auto-renewal clause.
- Ask what chargeback tools are included — alerts and descriptor support should be built in, not upsold.
The short version: Peptide merchants pay more because regulators, card networks, and chargeback math say so — typically 3.5–6% all-in, plus a rolling reserve. The base costs (interchange, network registration) are real; padded contracts, 10%/180-day reserves that never shrink, and three-year lock-ins are not. And the cheapest quote in the market — a standard processor that hasn’t noticed you yet — is the most expensive account you can open.
Pay for Risk Once, Not Twice
Every peptide business pays for its risk category eventually. The only choice is whether you pay for it transparently, on a negotiated fee schedule — or all at once, on a Friday afternoon, in a frozen-funds email.
If you’re comparing quotes right now, get one built for this industry. Request a line-by-line pricing quote from Great West Pay — underwriting that knows the peptide space, reserve terms with a scheduled review, and no fee you’ll discover for the first time on a statement.
